Vision Point Advisory Group, LLC Repligen Corp Transaction History
Vision Point Advisory Group, LLC
- $485 Million
- Q4 2025
A detailed history of Vision Point Advisory Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 1,434 shares of RGEN stock, worth $218,498. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,434Holding current value
$218,498% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
531Shares Held
59.2MCall Options Held
321KPut Options Held
667K-
Black Rock Inc. New York, NY7.57MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$769 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$534 Million0.05% of portfolio
-
United Capital Financial Advisers, LLC Newport Beach, CA2.76MShares$420 Million2.74% of portfolio
-
State Street Corp Boston, MA1.8MShares$275 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.46B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....